Inovio Pharmaceuticals
INO
#9349
Rank
NZ$0.18 B
Marketcap
NZ$2.23
Share price
-4.41%
Change (1 day)
-36.08%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.93. In 2024 the company made an earnings per share (EPS) of NZ-$6.76 an increase over its 2023 EPS that were of NZ-$10.43.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-28.97%
2024NZ-$6.76-35.14%
2023NZ-$10.43-56.62%
2022NZ-$24.04-19.54%
2021NZ-$29.8835.9%
2020NZ-$21.99-11.57%
2019NZ-$24.8615.24%
2018NZ-$21.57-2.78%
2017NZ-$22.196.93%
2016NZ-$20.75134.88%
2015NZ-$8.84-29.51%
2014NZ-$12.53-57.34%
2013NZ-$29.38146.55%
2012NZ-$11.9220.83%
2011NZ-$9.86-29.41%
2010NZ-$13.97-48.48%
2009NZ-$27.1210%
2008NZ-$24.6611.11%
2007NZ-$22.19-41.3%
2006NZ-$37.81-66.91%
2005NZ-$114.24110.61%
2004NZ-$54.25-61.63%
2003NZ-$141.37186.67%
2002NZ-$49.31
2001N/A-100%
2000NZ-$39.45-63.64%
1999NZ-$108.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.96-403.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.02-343.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.24-145.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.73-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.09-223.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.65-234.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ$0.60-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA